---
category: news
title: "Oricell Obtained FDA IND Clearance of OriCAR-017, a Novel GPRC5D Targeted CAR-T Cell Therapy for R/R MM."
excerpt: "Oricell Therapeutics (Oricell), a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the companyâ€™s Investigational New Drug (IND) application for OriCAR-017 for patients with relapsed/refractory multiple myeloma (R/R MM)."
publishedDateTime: 2024-01-30T07:27:00Z
originalUrl: "https://www.healthcaredive.com/press-release/20240130-oricell-obtained-fda-ind-clearance-of-oricar-017-a-novel-gprc5d-targeted-c-1/"
webUrl: "https://www.healthcaredive.com/press-release/20240130-oricell-obtained-fda-ind-clearance-of-oricar-017-a-novel-gprc5d-targeted-c-1/"
type: article
quality: 17
heat: 17
published: false

provider:
  name: Healthcare Dive
  domain: healthcaredive.com

topics:
  - AI in Healthcare
  - AI

secured: "Cq/naPt3Wk++7NmTyWZnZUV+5FqvFhQbnexl5Vb0XusDm+ZUSaB/5rtfDsZfC0CeAmkYQf4mScvgmlthrpmz5ahLANlxaIlmAvOtLRBna/JRe6qI0W5zIh+Rfz3bTsZpIUE3wKbd243qNlloGMYFJ3cEHhUSEJyLReBShxudcXz+t4t7Eidqwy2TqjlRVKGL7JjSvDt07tHXUSPzWh7PQAx4YEHxDQUuUFf0OUhR3DPhZmsYUzktVl1ml+X1rSnRp4XRvhRr7QFHazUZmaVhvGicibR24ZmmlHzcm82ZQyTh+7KND1KU++bfe1O3xYbRJnhV13PGRqVRX0l1w+mQA1L65oTYZYqm2ADkn3hBJPk=;JBdyTJTSv/ODt3xsoepBFw=="
---

